In brief: Multiple Sclerosis Society

The Multiple Sclerosis Society has condemned as 'breathtaking bungling' the announcement by the National Institute for Clinical Excellence that no decision on the drugs beta interferon and glatiramer acetate will be made before July 2001. NICE said new evidence had come to light which needed to be taken into account.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here